Efficacy and Safety of CagriSema for Metabolic Outcomes
CagriSema showed larger metabolic improvements than comparators, though variable study results mean benefits may differ across individuals.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Association of tirzepatide versus Glucagon-Like Peptide-1 receptor…
People taking tirzepatide had fewer recorded dental problems than those on GLP-1 drugs, though confirmation in prospective studies is needed.
Novel or significantly improved treatmentLenalidomide maintenance after initial immunochemotherapy in chronic…
Lenalidomide maintenance extended disease control in some chronic lymphocytic leukemia patients, but side effects were significant and survival didn't improve.
Near-term implementable findingAn Artificial Intelligence-Based Preoperative Planning System for…
An AI tool planned high-tibial-osteotomy surgery as accurately as manual methods but far faster, promising streamlined preparation.
Early cancer detection or preventionctDNA in the Management of Resectable & Advanced Colorectal Cancer
Circulating tumor DNA shows promise for predicting colorectal cancer outcomes, though its clinical value in decision-making remains uncertain.